Company BioLineRx Ltd. TEL AVIV STOCK EXCHANGE
Equities
BLRX
IL0011015182
Biotechnology & Medical Research
Business Summary
Sales per Business
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
License
96.0
%
| - | - | 17 | 96.0 % | - |
Oncology and Hematology
4.0
%
| 0 | nan % | 1 | 4.0 % | - |
Sales per region
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 0 | nan % | 18 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 63 | 09-05-23 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 17-08-31 |
John Lacey
IRC | Investor Relations Contact | - | - |
Asaf Aloni
PRN | Corporate Officer/Principal | - | - |
Tali Yaron Dalah
AUD | Comptroller/Controller/Auditor | 46 | - |
Ella Sorani
PRN | Corporate Officer/Principal | 56 | 17-01-31 |
Holly May
PRN | Corporate Officer/Principal | - | 22-06-15 |
Corporate Officer/Principal | - | 19-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 14-02-23 |
Avraham Molcho
BRD | Director/Board Member | 66 | 09-12-31 |
Aharon Schwartz
CHM | Chairman | 80 | 03-12-31 |
Director/Board Member | 65 | 13-08-18 | |
Raf Hofstein
BRD | Director/Board Member | 74 | 02-12-31 |
Rami Dar
BRD | Director/Board Member | 67 | 22-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,199,089,165 | 1,194,817,450 ( 99.64 %) | 0 | 99.64 % |
Company contact information
BioLineRx Ltd.
Modi'in Technology Park 2 HaMa'ayan Street
7177871, Modi'in
+972 8 642 9100
http://www.biolinerx.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |